Значок книги

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy

Aim: Accurate causality assessment (CA) of adverse events (AEs) is important in clinical research and routine clinical practice. The Naranjo scale (NS) used for CA lacks specificity, leading to a high rate of false positive causal associations. NS is a simple scale for CA; however, its limitations h...

Полное описание

Сохранить в:

Библиографические подробности
Главные авторы:	Jyoti Bhagatram Sharma (Автор), Manjunath Nookala Krishnamurthy (Автор), Ankita Awase (Автор), Amit Joshi (Автор), Vijay Patil (Автор), Vanita Noronha (Автор), Kumar Prabhash (Автор), Vikram Gota (Автор)
Формат:	‌
Опубликовано:	SAGE Publishing, 2021-02-01T00:00:00Z.
Предметы:	article
Online-ссылка:	Connect to this object online.
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis
по: Zhong AY, и др.
Опубликовано: (2015)

Lenvatinib and pembrolizumab versus platinum doublet chemotherapy as second-line therapy for advanced or recurrent endometrial cancer
по: Yutaka Yoneoka, и др.
Опубликовано: (2024)

Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer
по: Yangchun Gu, и др.
Опубликовано: (2021)

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet
по: Hope Cottrill MD, и др.
Опубликовано: (2018)

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells
по: Seiji Isonishi, и др.
Опубликовано: (2022)

Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer
по: Leda Severi, и др.
Опубликовано: (2018)

Oral metronomic therapy in head and neck cancer - Authors' reply
по: Vijay Patil, и др.
Опубликовано: (2021)

Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
по: Mio Tadashi, и др.
Опубликовано: (2010)

In Doublet and Hose: A Story for Girls
по: Madison, Lucy Foster, 1865-1932; DeLand, Clyde O., 1872-1947 [Illustrator]

A doublet pair drop and dribble
по: Bacić Cica Z.
Опубликовано: (2019)

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
по: Xin Li, и др.
Опубликовано: (2021)

Solario the Tailor: His Tales of the Magic Doublet
по: Bowen, William, 1877-1937; Ormsbee, J. [Illustrator]

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
по: Ruby Maharjan, и др.
Опубликовано: (2019)

Chicken pox infection in patients undergoing chemotherapy: A retrospective analysis from a tertiary care center in India
по: Vanita Noronha, и др.
Опубликовано: (2017)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
по: Abhishek Mahajan, и др.
Опубликовано: (2023)

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
по: Chun-Hua Zhou, и др.
Опубликовано: (2021)

The Devastating Impact of the Earthquake Doublet: An Alarming Increase in Child Mortality
по: Uğurcan Sayılı, и др.
Опубликовано: (2024)

Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
по: Shirsat A, и др.
Опубликовано: (2021)

Edema of the face and extremities secondary to pemetrexed
по: Thomas Doyle, MS, и др.
Опубликовано: (2023)

Anaphylactic Reaction to Pemetrexed: A Case Report
по: Heloise Capelle, и др.
Опубликовано: (2014)

Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin
по: Rudra Pangeni, и др.
Опубликовано: (2018)

Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
по: Chen JH, и др.
Опубликовано: (2016)

Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
по: Ranjit K Goudar
Опубликовано: (2008)

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
по: Derek B. Oien, и др.
Опубликовано: (2018)

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet
по: Nakul Dar, BS, и др.
Опубликовано: (2024)

Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
по: Yuzo Sato, и др.
Опубликовано: (2021)

The role of pemetrexed in recurrent epithelial ovarian cancer: a scoping review
по: Michael Roche, и др.
Опубликовано: (2018)

Nanocarriers containing platinum compounds for combination chemotherapy
по: Guihua Fang, и др.
Опубликовано: (2022)

Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance
по: Takehiro Nakao, и др.
Опубликовано: (2024)

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
по: Steven F Powell, и др.
Опубликовано: (2009)

Patient advocacy and support groups in India: focus on lung cancer
по: Vanita Noronha, и др.
Опубликовано: (2024)

OUR EXPERIENCE WITH PEMETREXED/ CISPLATIN AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED NON- SQUAMOUS NON- SMALL CELL LUNG CANCER
по: Deyan N. Davidov
Опубликовано: (2013)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
по: Afifah NN, и др.
Опубликовано: (2020)

Doublet vs Single-Agent Maintenance Therapy in the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis
по: Qi J, и др.
Опубликовано: (2020)

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
по: Benjamin K. Schneider, и др.
Опубликовано: (2019)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
по: Enriqueta Felip, и др.
Опубликовано: (2008)

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
по: Serena Ricciardi, и др.
Опубликовано: (2009)

Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed
по: Dong Han Won, и др.
Опубликовано: (2020)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
по: G.S Tufatulin, и др.
Опубликовано: (2011)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
по: G.S Tufatulin, и др.
Опубликовано: (2011)